TCL Archive NLST Shows 20.3 Percent Mortality Benefit For CT Vs. X-Ray In Lung Cancer Screening November 5, 2010
TCL Archive This month’s 8-page Business & Regulatory Report included in this issue. January 30, 2004
TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. September 28, 2001
TCL Archive NCAB To Consider Fate Of Existing Two Proposed Comp Center At Important Meeting April 28, 1978
